The total size of the biological safety cabinet market was USD 276.8 million in 2022, which will power at a CAGR of 7.9% by the end of this decade, to touch USD 507.1 million by 2030.
 |
| To learn more about this report: https://bit.ly/3IjgsHx |
In emerging countries, governments are investing profoundly for enhancing the amenities for manufacturing biologic and pharma drugs, set up new labs, and offer better healthcare.
The developing nations are also altering their policies for the expansion of their healthcare infra budget, for encouraging the innovation of pharma products, for example vaccines.
The class II category had the largest revenue share, about 50%, in 2022, and it will maintain its dominance in the near future as well. This is because of the high acceptance of class II biosafety cabinets since they offer strong protection to the sample, along with the user and the surrounding environment.
North America dominated the biological safety cabinet market, with about 45%, as per a report published by a market research firm P&S Intelligence, and it will grow considerably in the future, because of the substantial R&D activities in the pharma and biotech industries, accompanied by the augmented risk of communicable diseases.
Furthermore, there will be a substantial growth in Europe, with the progression of the healthcare infra and favorable policies for taking safety initiatives for their staffs and the people. Also, there is new R&D infra for boosting the growth of region which, will power the industry.
APAC has a growing prevalence of communicable diseases; therefore, reassuring the requirement for cleanroom tech solutions, such as biological safety cabinets in healthcare surroundings.
Furthermore, the growing acceptance of cleanroom solutions for the production and packing of biotech products is supporting the industrial growth.
Because of the rising prevalence of chronic diseases all over the world, the demand for biological safety cabinets will rise even more in the future.
